Coherent Biopharma

Private

SuzhouHealthcare & Life Scienceshttp://www.coherentbiopharma.com/

Last Round

Series B

May 23, 2023

Total Funding Raised

$128M

Company Overview

Coherent Biopharma is a clinical-stage biopharmaceutical company that develops bispecific-targeting ligand drug conjugates (Bi-XDC) for the treatment of cancer and other chronic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Application

Keywords

Bi-XDC platformBi-specific, Bi-ligand Drug Conjugatestargeted cancer therapyclinical stage biopharmaoncology drug candidatessmall molecule drug conjugateprecision oncologyC-PROTAC platformbiopharma licensingtargeted protein degradationsolid tumor therapydrug delivery platformAI drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Coherent Biopharma Comps

Public and private peers based on sector, stage, and business model.

Coherent Biopharma comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Coherent Biopharma Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	May 23, 2023
Series A Extension	Oct 10, 2018

View all Funding Rounds

Coherent Biopharma Investors

Notable investors and investment history

Coherent Biopharma investors
Investor	Rounds
Agricultural Bank of China International	Series B
Hefei Industry Investment Group	Series B
6 Dimensions Capital	Series A Extension
Hefei Hi-Tech VC	Series B

View all Investors

Coherent Biopharma Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Coherent Biopharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Coherent Biopharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersSuzhou

Year Founded2016

Last FundingMay 23, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.